Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Vet Intern Med ; 29(6): 1667-75, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26391904

RESUMO

BACKGROUND: Equine neuroaxonal dystrophy/equine degenerative myeloencephalopathy (NAD/EDM) is a neurodegenerative disorder affecting genetically predisposed foals maintained on α-tocopherol (α-TP)-deficient diet. OBJECTIVE: Intramuscular α-TP and selenium (Se) administration at 4 days of age would have no significant effect on serum or cerebrospinal fluid (CSF) α-TP in healthy foals. Serum and CSF α-TP, but not Se, would be significantly decreased in NAD/EDM-affected foals during first year of life. ANIMALS: Fourteen Quarter horse foals; 10 healthy foals supplemented with 0.02 mL/kg injectable α-TP and Se (n = 5) or saline (n = 5) at 4 days of age and 4 unsupplemented NAD/EDM-affected foals. METHODS: Complete neurologic examinations were performed, blood and CSF were collected before (4 days of age) and after supplementation at 10, 30, 60, 120, 180, 240, and 360 days of age. Additional blood collections occurred at 90, 150, 210, and 300 days. At 540 days, NAD/EDM-affected foals and 1 unsupplemented healthy foal were euthanized and necropsies performed. RESULTS: Significant decreases in blood, CSF α-TP and Se found in the first year of life in all foals, with most significant changes in serum α-TP from 4-150 days. Dam α-TP and Se significantly influenced blood concentrations in foals. Injection of α-TP and Se did not significantly increase CSF Se, blood or CSF α-TP in healthy foals. NAD/EDM-affected foals had significantly lower CSF α-TP through 120 days. CONCLUSIONS AND CLINICAL IMPORTANCE: Injection of α-TP and Se at 4 days of age does not significantly increase blood or CSF α-TP. Despite all 14 foals remaining deficient in α-TP, only the 4 genetically predisposed foals developed NAD/EDM.


Assuntos
Doenças dos Cavalos/sangue , Distrofias Neuroaxonais/veterinária , Selênio/líquido cefalorraquidiano , alfa-Tocoferol/líquido cefalorraquidiano , Animais , Animais Recém-Nascidos , Feminino , Predisposição Genética para Doença , Doenças dos Cavalos/líquido cefalorraquidiano , Doenças dos Cavalos/genética , Cavalos , Masculino , Distrofias Neuroaxonais/sangue , Distrofias Neuroaxonais/líquido cefalorraquidiano , Distrofias Neuroaxonais/genética , Distrofias Neuroaxonais/prevenção & controle , Selênio/administração & dosagem , Selênio/sangue , Selênio/farmacologia , alfa-Tocoferol/administração & dosagem , alfa-Tocoferol/sangue , alfa-Tocoferol/farmacologia
2.
J Hered ; 96(7): 750-4, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15958795

RESUMO

Hyperuricosuria, an autosomal recessive disorder, is characterized by high levels of uric acid in the urine of Dalmatian dogs. Whereas high levels of uric acid are known to be caused by the silencing of the urate oxidase (uox) gene in humans and higher primates, the molecular basis for the Dalmatian defect is unknown. Transplantation studies show that the organ responsible for the Dalmatian phenotype is the liver, which is where urate oxidase is exclusively expressed and uric acid is converted into allantoin. We cloned and sequenced the canine uox cDNA and compared the sequence between a Dalmatian and non-Dalmatian dog. No change in cDNA sequence was identified. A Dalmatian x pointer backcross family was used to track the segregation of microsatellite markers surrounding the urate oxidase locus. The uox gene was excluded for Dalmatian hyperuricosuria based on the cDNA sequence identity and negative LOD scores.


Assuntos
Doenças do Cão/genética , Urato Oxidase/genética , Ácido Úrico/urina , Animais , Sequência de Bases , Clonagem Molecular , DNA Complementar/química , Cães , Genótipo , Endogamia , Escore Lod , Masculino , Camundongos , Repetições de Microssatélites/genética , Dados de Sequência Molecular , Papio , Análise de Sequência de DNA , Suínos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA